Skip to main content
. 2022 Jan 9;14(1):153. doi: 10.3390/pharmaceutics14010153

Figure 8.

Figure 8

Figure 8

Figure 8

Effect of free TQ and PEG-Lip-TQ on body weight and LD50 (A) Average body weight by free TQ during the experiment period in phase 1, (B) Average body weight of surviving animals by free TQ after 14 days in phase 1, (C) Average body weight by free TQ during the experiment period in phase 2, (D) Average body weight of surviving animals by free TQ after 14 days in phase 2, (E) Average body weight by PEG-Lip-TQ during the experiment period in phase 1, (F) Average body weight of surviving animals by free PEG-Lip-TQ after 14 days in phase 1, (G) Average body weight by PEG-Lip-TQ during the experiment period in phase 2, (H) Average body weight of surviving animals by free PEG-Lip-TQ after 14 days in phase 2, (I) LD50 of free TQ and PEG-Lip-TQ. The values are expressed as mean ± SE of three independent experiments. * Significant difference between the treated groups, p-value < 0.05, **** Significant difference between the treated groups, p-value < 0.0001.